Job title: Director of Oncology Chemistry and Programme Leader
Dr Elisabetta Chiarparin has nearly 20 years drug discovery experience in the CNS and Oncology therapeutic areas, acquired at GSK, Astex Pharmaceuticals and AstraZeneca, and she has contributed to the discovery of several preclinical and clinical candidates. Elisabetta has co-authored more than 45 publications. Elisabetta is a committee member of the Organic division of Royal Society of Chemistry and BMCS Lecturer. Elisabetta holds a Ph.D. in Chemistry from the University of Lausanne, Switzerland and post-doc in Structural Biology and Biophysics at Aventis Pharma Paris France.
Panel: Our Social Media Feeds Are Personalized – Why Isn’t Our Medical Treatment? 1:00 pm
The journey to personalized medicine and the role epigenetics will play How to design a drug development pipeline for precision medicine The future of personalised medicine – a pipe dream or legitimate goal? Read more
day: Virtual Conference Day